HARROW HEALTH INC's ticker is HROW and the CUSIP is 415858109.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $65,000 | -54.5% | 4,539 | -39.4% | 0.00% | – |
| Q2 2023 | $143,000 | +146.6% | 7,490 | +170.6% | 0.00% | – |
| Q1 2023 | $58,000 | +1.8% | 2,768 | -28.2% | 0.00% | – |
| Q4 2022 | $57,000 | +137.5% | 3,853 | +97.3% | 0.00% | – |
| Q3 2022 | $24,000 | +84.6% | 1,953 | +5.4% | 0.00% | – |
| Q2 2022 | $13,000 | -23.5% | 1,853 | -24.2% | 0.00% | – |
| Q1 2022 | $17,000 | +6.2% | 2,444 | +31.9% | 0.00% | – |
| Q4 2021 | $16,000 | -91.0% | 1,853 | -90.5% | 0.00% | – |
| Q3 2021 | $178,000 | -57.1% | 19,579 | -56.1% | 0.00% | – |
| Q2 2021 | $415,000 | +44.1% | 44,610 | +4.9% | 0.00% | – |
| Q1 2021 | $288,000 | -1.7% | 42,513 | -0.4% | 0.00% | – |
| Q4 2020 | $293,000 | +7225.0% | 42,671 | +5826.5% | 0.00% | – |
| Q3 2020 | $4,000 | 0.0% | 720 | -1.0% | 0.00% | – |
| Q2 2020 | $4,000 | +33.3% | 727 | 0.0% | 0.00% | – |
| Q1 2020 | $3,000 | -50.0% | 727 | +1.0% | 0.00% | – |
| Q4 2019 | $6,000 | +50.0% | 720 | -1.2% | 0.00% | – |
| Q3 2019 | $4,000 | -33.3% | 729 | +1.2% | 0.00% | – |
| Q2 2019 | $6,000 | +50.0% | 720 | 0.0% | 0.00% | – |
| Q1 2019 | $4,000 | – | 720 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 3,775,000 | $71,876,000 | 17.19% |
| Private Capital Management, LLC | 1,152,346 | $21,940,668 | 2.61% |
| Birchview Capital, LP | 150,000 | $2,856,000 | 2.14% |
| Portolan Capital Management | 1,098,999 | $20,924,941 | 1.85% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 85,164 | $1,621,523 | 1.83% |
| Ophir Asset Management Pty Ltd | 354,679 | $6,753,088 | 1.41% |
| Diametric Capital, LP | 149,571 | $2,847,832 | 1.27% |
| INVICTUS PRIVATE WEALTH, LLC | 508,316 | $9,678,337 | 1.04% |
| BRAIDWELL LP | 1,452,538 | $27,656,324 | 0.90% |
| Westside Investment Management, Inc. | 133,744 | $2,546,486 | 0.72% |